Disease of aging
Sarcopenia
Last updated Sun May 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
What it is
Sarcopenia is age-related loss of skeletal muscle quantity and quality. The EWGSOP2 definition requires:
- Low muscle strength (grip strength or chair-rise) — the defining criterion.
- Low muscle quantity or quality (DEXA appendicular lean mass index, ultrasound, BIA).
- Optionally: low physical performance (gait speed) for severity.
Why it matters
- Muscle mass and strength independently predict all-cause mortality.
- Underlies most falls and hip fractures in older adults.
- Worsens insulin resistance, cardiometabolic risk.
- Reduces resilience to surgery, hospitalisation, and acute illness.
Risk factors
- Inactivity (the dominant cause).
- Inadequate protein intake.
- Inflammation, chronic disease (cancer, CKD, COPD).
- Hormonal (low testosterone, menopausal estrogen loss).
- Vitamin D deficiency.
- Prolonged bed rest / immobilisation.
What works
- Resistance training (the single most effective intervention; gains possible even in 90-year-olds).
- Adequate protein (1.2–1.6 g/kg/day in older adults, distributed across meals).
- Creatine monohydrate amplifies training response.
- Treat reversible contributors: vitamin D, hypogonadism, depression.
- Avoid sedentary recovery after acute illness.
Related entries
References
- Cruz-Jentoft, A. J. et al. Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2). Age Ageing 48, 16–31 (2019).